# Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

> **NCT00366782** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 51 (actual)

## Conditions studied

- Paramyxoviridae Infections
- Virus Diseases

## Interventions

- **BIOLOGICAL:** rB/HPIV3
- **BIOLOGICAL:** rB/HPIV3
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00366782
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-06
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2012-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366782, "Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00366782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*